BioSpace News Archive

Genetown

Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Radius Pharmaceuticals, Inc. presented real-world evidence from an analysis comparing the effectiveness of TYMLOS® (ABL) to teriparatide (TPTD) in women with osteoporosis ages 50 years and older who were new to anabolic therapy (n=43,352).

April 16, 2024
·
7 min read
Biotech Beach

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024

enVVeno Medical Corporation today announced that additional topline efficacy data from the VenoValve U.S. pivotal trial will be presented at the 2024 Charing Cross International Symposium being held April 23rd - 25th in London, England.

April 16, 2024
·
6 min read
Kane Biotech to Host Investor Webinar

Kane Biotech Inc. announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern Time.

April 16, 2024
·
2 min read
Business

The Nomination Committee’s proposal for the election of Board members and Chairperson of the Board in BioArctic AB

BioArctic AB hereby announces that the Nomination Committee for BioArctic AB presents the following proposals regarding the resolution on the number of board members and the election of board members and Chairperson of the Board at the Annual General Meeting on May 22, 2024.

April 16, 2024
·
4 min read
Drug Development

IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two

IGC Pharma, Inc. (“IGC Pharma,” “IGC,” or the “Company”) (NYSE American: IGC) today announced that interim data from its Phase 2 clinical trial demonstrates a clinically significant reduction, approaching statistical significance, in agitation in Alzheimer’s at week two compared to placebo.

April 16, 2024
·
5 min read
Biotech Bay

Biolog Expands the Odin Family, and Access to Cellular Characterization, With the Launch of Odin VIII

Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic and metabolic profiling products and services, announced the launch of OdinTM VIII system, the newest member of its Odin family of instruments.

April 16, 2024
·
2 min read
SAB Biotherapeutics Provides SAB-142 Trial Update

SAB Biotherapeutics, Inc. today announced their Chief Medical Officer, Dr. Alexandra Kropotova, MD, MBA disclosed that SAB has completed dosing the third cohort for SAB-142.

April 16, 2024
·
5 min read
Business

Cardiawave appoints Olivier Pierron as its Chief Executive Officer

Cardiawave SA, a French Medtech company that has developed an innovative Non-Invasive Ultrasound Therapy (NIUT) device for the treatment of severe symptomatic calcific aortic stenosis, is delighted to announce the appointment of Olivier Pierron as its new Chief Executive Officer.

April 16, 2024
·
3 min read
IRLAB to Present at Redeye Investor Forum - April 16, 2024

IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present at Redeye Investor Forum on April 18.

April 16, 2024
·
1 min read
Business

Faron Confirms Plans for the Coming Months Under New Leadership - April 16, 2024

Faron Pharmaceuticals Ltd. announces ongoing plans and activities for the coming months following the recent announcement of the proposed appointment of Dr. Juho Jalkanen as Chief Executive Officer, effective 1 May 2024.

April 16, 2024
·
3 min read